Yahoo
OTC Markets OTCPK - Delayed Quote USD

Helix BioMedix, Inc. (HXBM)

3.2900 0.0000 (0.00%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for HXBM
  • Previous Close 3.2900
  • Open 6.0200
  • Bid 4.0000 x 12500
  • Ask 7.0000 x 20000
  • Day's Range 6.0200 - 6.0200
  • 52 Week Range 1.0000 - 6.5000
  • Volume 100
  • Avg. Volume 120
  • Market Cap (intraday) 739,289
  • Beta (5Y Monthly) 1.86
  • PE Ratio (TTM) --
  • EPS (TTM) -1.6500
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

www.helixbiomedix.com

8

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HXBM
64.50%
S&P 500 (^GSPC)
12.32%

1-Year Return

HXBM
6.00%
S&P 500 (^GSPC)
13.54%

3-Year Return

HXBM
85.86%
S&P 500 (^GSPC)
76.41%

5-Year Return

HXBM
86.73%
S&P 500 (^GSPC)
64.28%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -125.06%

  • Return on Assets (ttm)

    -59.00%

  • Return on Equity (ttm)

    -122.53%

  • Revenue (ttm)

    2.07M

  • Net Income Avi to Common (ttm)

    -2.58M

  • Diluted EPS (ttm)

    -1.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    216.53k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.08M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: